Spero Therapeutics

Spero

This biopharmaceutical company develops medicines for immune-mediated diseases and multi-drug resistant bacterial infections for patients with unmet medical needs.

Serestherapeutics

This company develops microbiome live biotherapeutics for patients with antimicrobial resistant infections and gastrointestinal-related immune diseases.

Qpex Biopharma

This biopharmaceutical company develops novel anti-infective therapies for patients with drug-resistant bacterial infections in inpatient and outpatient settings.

Clarametyx Biosciences

This company develops immune-enabling therapies targeting bacterial biofilms for patients with chronic and progressive respiratory diseases.

Vir Biotechnology

This company develops antibody-based medicines and immunotherapies for patients with serious infectious diseases and cancer.

Nabriva

This biopharmaceutical company develops and commercialises novel antibiotics for patients with serious infections caused by drug-resistant bacteria.

Paratek

This company develops and supplies antibiotics and specialty medicines for healthcare providers treating serious infectious diseases and osteoporosis.

Silverback Therapeutics

This biopharmaceutical company develops immune-modulating therapeutics for patients with cancer and chronic viral infections.